FcRn (FCGRT & B2M) Antibody

• Catalog Number: orb1806351
• Category: Antibodies
• Description: Anti-FcRn (FCGRT & B2M) Reference Antibody is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
• Target: FcRn (FCGRT & B2M)
• Clonality: Monoclonal
• Conjugation: Unconjugated
• Reactivity: Human, Monkey
• Concentration: 1 mg/mL
• Buffer/Preservatives: 100 mM Proline/Acetic acid 20mM Arginine pH 5.0
• Purity: > 95%
• Purification: Protein A
• UniProt ID: P55899
• MW: 145.2 kDa
• Tested applications: ELISA, FA, FACS, In vivo
• Expression System: CHO
• Endotoxins: < 0.001 EU/ug
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only

Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab)is more than 97.55% ;determined by SEC-HPLC.

Immobilized FcRn(FCGRT) His+FcRn(B2M) at 2 μg/mL can bind Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab);EC50=0.0103μg/mL.